MyFinsight
Home
Blog
About
BioCardia, Inc. (BCDA)
BioCardia, Inc. (BCDA)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$1,735K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from sales of common st...
Reduction in the carrying amount...
Share-based compensation
Others
Negative Cash Flow Breakdown
Net loss
Payable
Issuance costs of sale of common...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-1,613
-2,259
-1,984
-1,483
Depreciation
3
3
3
4
Reduction in the carrying amount of right-of-use assets
121
121
182
103
Share-based compensation
109
113
85
77
Allowance for doubtful accounts
-
-
0
0
Receivable
10
-
20
-10
Prepaid expenses and other current assets
-18
-47
138
-131
Payable
-255
247
-365
-213
Accrued expenses and other current liabilities
20
197
-73
-194
Operating lease liability
-128
-128
-187
-107
Net cash used in operating activities
-1,735
-1,659
-2,497
-1,672
Purchase of property and equipment
0
3
6
0
Net cash used in investing activities
0
-3
-6
0
Exercise of common stock warrants
39
-
5
-
Taxes paid related to net share settlement of equity awards
-
-
197
-
Proceeds from sales of common stock
5,084
225
0
6,783
Issuance costs of sale of common stock
222
108
96
804
Net cash provided by financing activities
4,901
117
-288
5,979
Net change in cash and cash equivalents
3,166
-1,545
-2,791
4,307
Cash and cash equivalents at beginning of period
951
2,496
980
980
Cash and cash equivalents at end of period
4,117
951
2,496
5,287
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from sales of
common stock
$5,084K
(166.60%↑ Y/Y)
Exercise of common stock
warrants
$39K
Net cash provided by
financing activities
$4,901K
(161.11%↑ Y/Y)
Canceled cashflow
$222K
Net change in cash
and cash...
$3,166K
(327.61%↑ Y/Y)
Canceled cashflow
$1,735K
Issuance costs of sale of
common stock
$222K
(640.00%↑ Y/Y)
Reduction in the carrying
amount of right-of-use...
$121K
(-38.27%↓ Y/Y)
Share-based compensation
$109K
(-59.33%↓ Y/Y)
Accrued expenses and
other current...
$20K
(-95.52%↓ Y/Y)
Prepaid expenses and
other current assets
-$18K
(57.14%↑ Y/Y)
Depreciation
$3K
(-82.35%↓ Y/Y)
Net cash used in
operating activities
-$1,735K
(46.89%↑ Y/Y)
Canceled cashflow
$271K
Net loss
-$1,613K
(66.12%↑ Y/Y)
Payable
-$255K
(-134.41%↓ Y/Y)
Operating lease liability
-$128K
(37.86%↑ Y/Y)
Receivable
$10K
(0.00%↑ Y/Y)
Buy us a coffee